Circulating endothelial cells in patients with heart failure and left ventricular dysfunction

Disease Markers

Volumn 31, Issue 2, 2011, Pages 75-82

  Martínez Sales, Vicenta ^a   Sánchez Lázaro, Ignacio ^a   Vila, Virtudes ^a   Almenar, Luis ^a   Contreras, Teresa ^b   Reganon, Edelmiro ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

angiogenesis; circulating endothelial cells; endothelial dysfunction; Heart failure

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; THROMBOSPONDIN 1; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL INJURY; CARDIAC PATIENT; CIRCULATING ENDOTHELIAL CELL; CLINICAL ARTICLE; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ENDOTHELIAL MICROPARTICLE; FEMALE; HEART LEFT VENTRICLE FAILURE; HOSPITAL ADMISSION; HUMAN; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 80052688671     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0801     Document Type: Article

References (29)

1. J. Quilici, N. Banzet, P. Paule, J.B. Meynard, M. Mutin, J.L. Bonnet et al., Circulating endothelial cells count as a diag-nostic markerfornon-ST- elevation acute coronary syndromes, Circulation 110 (2004), 1586-1591. (Pubitemid 39297980)
2. A. Widman, F. Sabatier, L. Arnaud, L. Bonello, G. Al-Massarani, F. Paganelli et al., CD146-based immunomagnetic enrichment followed by multipara meter flow cytometry: anew approach to counting circulating endothelial cells, J Thromb Haemost 6 (2008), 869-876. (Pubitemid 351524550)
3. P. Mancuso, A. Burlini, G. Pruneri, A. Goldhirsch, G. Mar-tinelli and F. Bertolini, Resting and activated endothelial cells are increased in the peripheral blood of cancer patients, Blood 97 (2001), 3658-3661.
4. A.D. Blann, A. Woywodt, F. Bertolini, T.M. Bull, J.P. Buyon, R.M. Clancy et al., Circulating endothelial cells. Biomarkers of vascular diseases, Thromb Haemost 93 (2005), 228-235. (Pubitemid 40253726)
5. A. Woywodt, A.D. Blann, T. Kirsch, U. Erdbruegger, N. Banzet, M. Haubitz et al., Isolation and enumeration of circu-lating endothelial cells by immunomagnetic isolation: propos-al of a definition and a consensus protocol, J Thromb Haemost 4 (2006), 671-677.
6. A.Y. Chong, G.Y. Lip, B. Freestone and A.D. Blann, Increased circulating endothelial cells in acute heart failure: Comparison with von Willebrand factor and soluble E-selectin, Eur J Heart Fail 8 (2006), 167-172. (Pubitemid 43240851)
7. A.J. Makin, A.D. Blann, N.A. Chung, S.H. Silverman and G.Y. Lip, Assessment of endothelial damage in atherosclerot-ic vascular disease by quantification of circulating endothe-lial cells. Relationship with von Willebrand factor and tissue factor, Eur Heart J 25 (2004), 371-376. (Pubitemid 38391518)
8. A.Y. Chong, A.D. Blann, J. Patel, B. Freestone, E. Hughes and G.Y. Lip, Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brainnatriuretic peptide, Circulation 110 (2004), 1794-1798. (Pubitemid 39302656)
9. A.D. Blann, Plasma von Willebrand factor, thrombosis and the endothelium: the first 30 years, Thromb Haemost 95 (2006), 49-55.
10. B. Freestone, A.Y. Chong, Blann and G.Y. Lip, The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction, Thrombosis Res 118 (2006), 479-485. (Pubitemid 44308638)
11. V. Vila, V. Martinez-Sales, L. Almenar, I. Sánchez Lázaro, P. Villa and E. Reganon, Effect of oral anticoagulant therapy on thrombospondin-1 and von Willebrand factor in patients with stableheart failure, Thromb Res 121 (2008), 611-615. (Pubitemid 351305287)
12. A.D. Blann and A. Pretorius, Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins? Atherosclerosis 188 (2006), 12-18. (Pubitemid 44142547)
13. A.Y. Chong, B. Freestone, J. Patel, H.S. Lim, E. Hughes, A.D. Blann et al., Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes, Am J Cardiol 97 (2006), 671-675. (Pubitemid 43255037)
14. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. Mc Murray, P. Ponikowski, PA. Poole-Wilson et al., ESC guidelines forthe diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treat-ment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM), Eur J Heart Fail 10 (2008), 933-989.
15. C. Gürgün, M. Ildizli, O. Yavuzgil, A. Sin, A. Apaydin, C. Cinar etal., The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure, Int J Cardiol 123 (2008), 102-107. (Pubitemid 350250883)
16. V. Vila, V. Mart́nez-Sales, L. Almenar, I. Sánchez Lázaro, P. Villa and E. Reganon, Inflammation, endothelial dysfunction and angiogenesis markers in chronic heart failure patients, Int J Cardiol 130 (2008), 276-277.
17. G.Y. Lip and I. Chung, Vascular endothelial growth factor and angiogenesis in heart failure, J Card Fail 11 (2005), 285-287. (Pubitemid 40616898)
18. M. Hristov and C. Weber, Ambivalence of progenitor cells in vascular repair and plaque stability, Curr Opin Lipidol 19 (2008), 491-497.
19. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. Mc Murray, P. Ponikowski, PA. Poole-Wilson et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force forthe Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM), Eur Heart J 29 (2008), 2388-442.
20. V. Mart́nez-Sales, V. Vila, M. Ferrando and E. Reganon, Ator-vastatin neutralizes the up regulation of thrombospondin-1 in-duced by thrombin in human umbilical vein endothelial cells, Endothelium 14 (2007), 233-238. (Pubitemid 47543009)
21. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. Mc Murray, P. Ponikowski, PA. Poole-Wilson et al., ESC Guidelines forthe diagnosis and treatment of acute and chronic heart failure 2008, Eur Heart J 29 (2008), 2388-2442.
22. G. Balconi, R. Lehmann, F. Fiordaliso, B. Assmus, S. Dim-meler, P. Sarto et al., Levels of circulating pro-angiogenic cells predict cardiovascular outcomes in patients with chronic Heart Failure, J Card Fail 15 (2009), 747-755.
23. I.J. Sánchez-Lázaro, L. Almenar, E. Reganon, V. Vila, L. Mart́nez-Dolz, V. Mart́nez-Sales etal., Inflammatory mark-ers in stable heart failure and their relationship with functional class, Int J Cardiol 129 (2008), 388-393.
24. U. Erdbruegger, M. Haubitz and A. Woywodt, Circulating endothelial cells: a novel marker of endothelial damage, Clin Chim Acta 373 (2006), 17-26. (Pubitemid 44292176)
25. L. Bonello, K. Harhouri, F. Sabatier, L. Camoin-Jau, L. Arnaud, K. Baumstarck-Barrau et al., Level of Adenosine Diphosphate Receptor P2Y12 Blockade During Percutaneous Coronary Intervention Predicts the Extent of Endothelial In-jury, Assessed by Circulating Endothelial Cell Measurement JAm Coll Cardiol 56 (2010), 1024-1031.
26. U.M. Vischer, Von Willebrand factor, endothelial dysfunc-tion, and cardiovascular disease, J Thromb Haemost 4 (2006), 1186-1193.
27. L. Mart́nez-Dolz, L. Almenar, E. Reganon, V. Vila, C. Chamorro, L. Andrés et al., Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy, J Heart Lung Transplant 27 (2008), 760-766.
28. K.A. Eccles, H. Sowden, K.E. Porter, S.M. Parkin, S. Homer-Vanniasinkam and A.M. Graham, Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow, Atherosclerosis 200 (2008), 69-79.
29. M. Valgimigli, G.M. Rigolin, A. Fucili, M.D. Porta, O. Soukhomovskaia, P. Malagutti et al., CD34- and endothelial progenitor cells in patients with various degrees of congestive heartfailure, Circulation 110 (2004), 1209-1212.